Blood test study for pancreatic cancer
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a confirmed diagnosis of pancreatic cancer, a benign pancreatic condition, or be healthy.
- If you have pancreatic cancer, you may be planning surgery, chemotherapy, or radiation, depending on the group.
- You must not have had chemotherapy or radiation in the last 3 months if you have advanced pancreatic cancer.
- You must not have another active cancer (except non-melanoma skin cancer) or a known genetic condition that increases cancer risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
This study looks at blood samples from people with early-stage pancreatic cancer to understand how the immune system behaves. The goal is to find better treatments. If you have pancreatic cancer that hasn't spread, they may ask you to donate blood for research.
This study uses a blood test to look at how your immune system responds, which may help tell if chronic pancreatitis could turn into pancreatic cancer. It aims to find better ways to monitor people with chronic pancreatitis and catch cancer earlier.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
This study aims to find new ways to detect liver, bile duct, and pancreatic cancers early using a blood test. It may help doctors diagnose these cancers sooner, when they are easier to treat.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.